News

Tracon Pharmaceuticals (Tracon) has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI). Under the terms of the agreement, both the companies

ChemPartner, a Shanghai based pre-clinical research company, is planning to enter into the European market by establishing ChemPartner Europe in Copenhagen in November – reported Copenhagen Capacity, the

The FDA has issued a Complete Response Letter to Amgen for its Biologic License Applications (BLA) for Prolia (denosumab) in the treatment and prevention of postmenopausal osteoporosis. Reportedly,

Alnara Pharmaceuticals (Alnara) has reported results from an international, phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase. Reportedly, liprotamase is a novel

MWV has received chain-of-custody certifications to the Forest Stewardship Council (FSC) and the Programme for the Endorsement of Forest Certification scheme (PEFC) for two of its packaging manufacturing

Medidata Solutions has reported a multi-year contract extension with Bristol-Myers Squibb for use of Medidata Grants Manager, an investigator site tool that helps sponsors ensure fair and consistent

Angiochem’s ANG1005 has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate phase 1 /2 clinical studies in patients

Allion Healthcare has entered into a definitive merger agreement with HIG Capital. As per the agreement, Allion will be acquired and taken private by an affiliate of HIG

Forest Laboratories and Cypress Bioscience have reported that Savella (milnacipran HCI) 100 mg/day (50 mg twice daily) demonstrated statistically significant and clinically meaningful concurrent improvements in pain, patient